Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000199217 | SCV000253626 | likely benign | Familial cancer of breast; Fanconi anemia complementation group J | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000409559 | SCV000489927 | likely benign | Fanconi anemia complementation group J | 2016-08-15 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000411112 | SCV000489928 | likely benign | Ovarian neoplasm | 2016-08-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001705155 | SCV000531752 | likely benign | not provided | 2019-03-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000561018 | SCV000668867 | likely benign | Hereditary cancer-predisposing syndrome | 2015-08-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000561018 | SCV000684245 | likely benign | Hereditary cancer-predisposing syndrome | 2016-07-27 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV003316108 | SCV004019343 | benign | Familial cancer of breast | 2023-02-28 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004767142 | SCV005381199 | likely benign | not specified | 2024-08-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004732778 | SCV005345132 | likely benign | BRIP1-related disorder | 2019-06-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |